Moderna
Trade Moderna 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRNA
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.
MRNA Key Statistics
Stock Snapshot
Moderna(MRNA) stock is priced at $142.73, giving the company a market capitalization of 57.94B. It carries a P/E multiple of -18.18.
During the trading session on 2026-08-24, Moderna(MRNA) shares reached a daily high of $159.47 and a low of $131.53. At a current price of $142.73, the stock is +8.5% higher than the low and still -10.5% under the high.
Trading volume for Moderna(MRNA) stock has reached 87.32M, versus its average volume of 42.66M.
Over the past 52 weeks, Moderna(MRNA) stock has traded between a high of $176.66 and a low of $22.28.
Over the past 52 weeks, Moderna(MRNA) stock has traded between a high of $176.66 and a low of $22.28.
MRNA News
Barclays analyst Eliana Merle raised the firm’s price target on Moderna (MRNA) to $125 from $48 and keeps an Equal Weight rating on the shares. The stock at cur...
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. Fo...
Moderna (NasdaqGS:MRNA) and Merck reported a successful Phase 3 trial of their personalized mRNA cancer vaccine, intismeran, in high risk melanoma patients. Th...
Analyst ratings
65%
of 26 ratingsMore MRNA News
Shares in Moderna (MRNA) climbed by 13% to $151 per share on Friday afternoon. This came even after JPMorgan’s five-star analyst Jessica Fye repeated her Sell r...
Key Points Moderna has made progress with two important products this year. The company boasts other promising pipeline candidates. It should have a much bet...
Technology Moderna's Cancer Vaccine: Are Investors Putting The Cart Before The Horse? Licensing Messenger RNA companies collectively added $92 billion to their...
Moderna Plunges 20% One Day After Cancer Vaccine Breakthrough Sent Shares Up 177% By Thomas Richmond Published Aug 20, 12:22PM EDT Quick Read Moderna (MRNA) s...
Moderna (MRNA) is down -19.9%, or -$34.73 to $139.65. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decision...
Yield Hunters Are Swarming This 6.3%-Dividend Stock—And Big-League Hedge Funds are Quietly Buying the Dip By Joey Frenette Published Aug 20, 11:34AM EDT Quick...
Moderna Sinks 18% After 177% Cancer Vaccine Rally, BioNTech Falls 4%, Merck Slips By David Moadel Published Aug 20, 11:23AM EDT Quick Read Moderna (MRNA) drop...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.